Archived research. Equity forecasting is part of the Runchey Research archive (methodology era 1) and is no longer actively updated. Everything remains published at its original URL. Browse the archive
Will any senior CE officer or director disclose an open-market purchase of CE common stock by December 31, 2026?
Current Prediction
Why This Question Matters
Insider activity is constructive-but-not-affirmative across two lenses (Insider Investigator, Fugazi Filter): no panic selling at depressed prices but no open-market buying at cycle lows either. A senior-officer open-market purchase by YE2026 would be a high-conviction governance affirmation that mgmt views the recovery thesis as live. This is asymmetrically informative — purchases are more reliable than sales for signal value. Absent purchase by YE2026 is the consensus-implied baseline; an actual purchase would shift GOVERNANCE_ALIGNMENT from MIXED toward ALIGNED.
Prediction Distribution
Individual Predictions(9 runs)
No open-market purchases at cycle lows in 2024-2025 — the conservative read. Stock has rallied off lows ($40-65 range) reducing 'asymmetric upside' argument for new purchases at $65. CE historical pattern: rare insider buying outside post-IPO/post-distress. Counter: 'any senior officer or director' is broad criterion; 8-month window. Director purchases more common at cycle lows. Net ~20%.
Q1 2026 earnings catalyst is upcoming. If earnings beat, mgmt has psychological window to 'validate the call' with purchases pre-narrative-confirmation. But mgmt comp is heavily stock-based — incremental buying not material. Director purchases more flexible. ~22%.
If mgmt high conviction, would have bought at $40-50 lows in 2024-2025. They didn't. Recent rally to $65 makes purchase less compelling psychologically. SEC trading windows constrain timing. ~18%.
Sector base rate: ~25-35% historical probability for distressed cyclical company over 12-month window. CE-specific reduction: no purchase at recent lows is conservative read. Net ~25%.
Begleiter equity-issuance question creates governance pressure for affirmative signal. Possible response: insider purchase as counter-narrative. But mgmt has shown reluctance. ~22%.
Stock pullback to $50 would reignite probability. At current $65, reduced. ~20%.
No purchases at lows. Rally reduces appeal. Broad criterion offsets. ~20%.
Director flexibility + 8-month window + governance pressure. ~22%.
Sector base rate adjusted for CE-specific MIXED signal. ~20%.
Resolution Criteria
Resolves YES if any current CE Section 16 officer (CEO, CFO, COO, GC, business unit presidents) or board director files a Form 4 between January 1, 2026 and December 31, 2026 disclosing an open-market purchase (transaction code 'P', not 'A' for award or 'M' for option exercise) of CE common stock with non-zero net cash outlay. Resolves NO if no such Form 4 is filed in the window.
Resolution Source
SEC EDGAR Form 4 filings for Celanese Corporation insider transactions
Source Trigger
Open-market insider purchase by any senior officer
Full multi-lens equity analysis